AAN/AHS Pharmacologic Treatment for Migraine Prevention in Adults 2026 Guideline

from Clinical Guideline InSights · host Guideline Central

The 2026 Pharmacologic Treatment for Migraine Prevention in Adults guideline, highlighting key recommendations across assessment of treatment efficacy, treatment of patients with or without comorbidities, assessment of adverse effects, and more. Pharmacologic Treatment for Migraine Prevention in AdultsAmerican Academy of Neurology/American Headache SocietyAugust 31, 2026Guideline Summary: https://www.guidelinecentral.com/guideline/5236152/ Full-Text: https://www.neurology.org/doi/10.1212/WNL.0000000000214881

Episode metadata supplied by the publisher feed · Published Sep 3, 2026

Embed this episode

Attribution link and audio player

Ready to play

AAN/AHS Pharmacologic Treatment for Migraine Prevention in Adults 2026 Guideline

0:00 12:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Guideline InSights?

This episode is 12 minutes long.

When was this Clinical Guideline InSights episode published?

This episode was published on September 3, 2026.

Can I download this Clinical Guideline InSights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!